ReviewBritish journal of pharmacology2019

The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects.

Ulf Neumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.